Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Radiology

Long-Term Monitoring and Peace of Mind

At a Glance

After a benign intraductal papilloma or vacuum-assisted excision, follow-up imaging is often done at about six months and then every 6–12 months for at least two years. Stable findings may return to annual screening, while new changes need reassessment.

Choosing active surveillance—or monitoring your breast after a procedure like Vacuum-Assisted Excision (VAE)—is a proactive way to manage your health while avoiding unnecessary surgery. While the word “surveillance” can sound intense, it is a standard approach for benign (non-cancerous) findings that have a very low risk of changing over time [1][2].

The Surveillance Schedule

There is no “one-size-fits-all” calendar for monitoring a papilloma, but most medical centers follow a structured path based on how the growth was first found.

  • The Initial Check: If you have just had a biopsy or a VAE, your first follow-up imaging usually happens about 6 months later [3]. Doctors often avoid scanning in the first 1 to 3 months because the biopsy site is still healing, which can make the images difficult to read [4].
  • The Two-Year Window: Most surveillance protocols involve imaging (typically ultrasound or mammography) every 6 to 12 months for at least two years, though this varies by center [2][5].
  • Stability is Key: If the area remains stable (no changes in size or appearance) for two years, your care team may transition you back to routine annual screening [6][2].

Understanding Recurrence Risk

If you had a VAE to remove the papilloma, there is a small chance it could return in the same spot.

  • Recurrence Rates: For benign papillomas without atypia, the recurrence rate is low, estimated at approximately 3.6% to 7.7% [2][3].
  • Residual Tissue: Recurrence is more likely if a small piece of the growth was left behind during the initial procedure (a “residual lesion”) [7].
  • Reassessment: If a papilloma does recur, it is often still benign. In studies where recurrent lesions were surgically removed, they were confirmed to be non-cancerous [2]. However, any new or enlarging finding still needs clinical and imaging reassessment.

Long-Term Outlook

For patients with a single, benign papilloma and no abnormal cells (atypia), the long-term outlook is very positive.

  • Site Risk: Large studies following patients for over five years found that cancer rarely develops at the exact site of a previously diagnosed benign papilloma [5][8].
  • General Risk: While having any benign breast “growth” can be associated with a slightly higher lifetime risk of breast cancer compared to someone with no breast changes, a simple papilloma is considered a low-risk finding [9][10]. Your doctor will look at your overall picture—including family history and other biopsy results—to give you a personalized risk assessment [11]. Be sure to continue routine screening for both breasts.

Managing “Scanxiety”

It is completely normal to feel a spike in stress or anxiety in the days leading up to a follow-up scan—a phenomenon often called scanxiety [12].

  • The Waiting Period: Research shows that anxiety is highest during the time between the scan itself and receiving the results [13].
  • Communication: Ask your care team exactly when and how you will receive your results (e.g., via a patient portal or a phone call) to reduce the stress of the unknown [14].
  • Coping Tools: Some patients find that integrated therapies, such as loving-kindness meditation or a brief massage before an appointment, may help lower self-reported anxiety levels [15][16], though effects vary by individual.

Remember, the goal of surveillance is to provide peace of mind by catching any changes in a timely manner.

Common questions in this guide

When should I have my first follow-up scan after a papilloma biopsy or VAE?
The first follow-up scan is often scheduled about six months after a biopsy or VAE. Imaging during the first one to three months may be avoided because healing changes can make breast images harder to interpret. Your care team may adjust the timing based on your procedure and findings.
How long will I need imaging follow-up for a benign intraductal papilloma?
Many centers use ultrasound or mammography every 6 to 12 months for at least two years. If the area remains unchanged for two years, your care team may return you to routine annual screening. The exact schedule depends on how the papilloma was found, its pathology, and whether it was completely removed.
How likely is a papilloma to come back after vacuum-assisted excision?
For a benign papilloma without atypia, reported recurrence is low, at about 3.6% to 7.7%. Recurrence is more likely when a small amount of the lesion remains after the procedure. A returning lesion is not automatically cancer, but a new or enlarging finding needs clinical and imaging reassessment.
Does a benign intraductal papilloma raise my future breast cancer risk?
A single benign papilloma without atypia is considered a low-risk finding, and cancer rarely develops at the same site. Benign breast changes may be linked with a slightly higher overall lifetime risk than having no breast changes. Your personal risk also depends on family history and other biopsy results.
If a papilloma comes back, will I automatically need surgery?
No. A recurrence does not automatically mean surgery or cancer. Your team may recommend updated imaging, another biopsy, continued monitoring, or removal depending on the finding’s size, appearance, pathology, and whether it is growing.
What can I do about anxiety before my follow-up scan?
Feeling anxious before a follow-up scan or while waiting for results is common. Ask your care team when and how results will be shared, and consider support from someone you trust. Relaxation practices such as meditation, deep breathing, or massage may help some people, although benefits vary.

Get notified when new evidence is published on intraductal papilloma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).

    Nakhlis F, Baker GM, Pilewskie M, et al.

    Annals of surgical oncology 2021; (28(5)):2573-2578 doi:10.1245/s10434-020-09215-w.

    PMID: 33047246
  2. 2

    Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up.

    Choi HY, Kim SM, Jang M, et al.

    Radiology 2019; (293(1)):72-80 doi:10.1148/radiol.2019190096.

    PMID: 31429678
  3. 3

    Ultrasound-Guided Vacuum-Assisted Excision to Treat Intraductal Papilloma.

    He P, Lei YT, Chen W, et al.

    World journal of surgery 2023; (47(3)):699-706 doi:10.1007/s00268-022-06735-2.

    PMID: 36624311
  4. 4

    Breast papillary lesions diagnosed and treated using ultrasound-guided vacuum-assisted excision.

    Li X, Gao H, Xu M, et al.

    BMC surgery 2020; (20(1)):204 doi:10.1186/s12893-020-00869-7.

    PMID: 32933518
  5. 5

    Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.

    Corbin H, Bomeisl P, Amin AL, et al.

    Human pathology 2022; (128()):90-100 doi:10.1016/j.humpath.2022.07.012.

    PMID: 35863513
  6. 6

    Vacuum-assisted complete excision of solid intraductal/intracystic masses and complex cysts: Is follow-up necessary?

    Quinn-Laurin V, Hogue JC, Pinault S, Duchesne N

    Breast (Edinburgh, Scotland) 2017; (35()):42-47 doi:10.1016/j.breast.2017.06.014.

    PMID: 28646723
  7. 7

    Intraductal papilloma of the breast: low risk, but handle with care.

    Nicosia L, Mariano L, Mallardi C, et al.

    La Radiologia medica 2026; (131(2)):238-246 doi:10.1007/s11547-025-02120-w.

    PMID: 41131397
  8. 8

    Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.

    Abbassi-Rahbar S, Sack S, Larson KE, et al.

    Annals of surgical oncology 2021; (28(10)):5768-5774 doi:10.1245/s10434-021-10520-1.

    PMID: 34338925
  9. 9

    Multiplicity of benign breast disease lesions and breast cancer risk in African American women.

    Patil V, Ruterbusch JJ, Chen W, et al.

    Frontiers in oncology 2024; (14()):1410819 doi:10.3389/fonc.2024.1410819.

    PMID: 38817898
  10. 10

    Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.

    Nasehi L, Sturgis CD, Sharma N, et al.

    Clinical breast cancer 2018; (18(6)):468-473 doi:10.1016/j.clbc.2018.06.011.

    PMID: 30017794
  11. 11

    Management of High-Risk Breast Lesions: A Comprehensive Update.

    Zamora KW, Komforti MK, Vorhis EB, et al.

    Journal of breast imaging 2026; (8(5)):477-494 doi:10.1093/jbi/wbag034.

    PMID: 42490060
  12. 12

    Women's experiences and preferences regarding breast imaging after completing breast cancer treatment.

    Brandzel S, Rosenberg DE, Johnson D, et al.

    Patient preference and adherence 2017; (11()):199-204 doi:10.2147/PPA.S122244.

    PMID: 28203064
  13. 13

    Surveillance-Associated Anxiety After Curative-Intent Cancer Surgery: A Systematic Review.

    Khatri R, Quinn PL, Wells-Di Gregorio S, et al.

    Annals of surgical oncology 2025; (32(1)):47-62 doi:10.1245/s10434-024-16287-5.

    PMID: 39343818
  14. 14

    Patient perspectives and preferences for communication of medical imaging risks in a cancer care setting.

    Thornton RH, Dauer LT, Shuk E, et al.

    Radiology 2015; (275(2)):545-52 doi:10.1148/radiol.15132905.

    PMID: 25803490
  15. 15

    Impact of loving-kindness meditation intervention vs. music intervention during biopsy on adherence to recommended breast cancer screening.

    Arrato NA, Soo MS, Wren AA, et al.

    Breast cancer research and treatment 2025; (212(2)):261-268 doi:10.1007/s10549-025-07721-7.

    PMID: 40377811
  16. 16

    Massage therapy in the breast imaging department: repurposing an ancient anxiety reducing method.

    Ashton JC, Bousquet D, Fevrier E, et al.

    Clinical imaging 2020; (67()):49-54 doi:10.1016/j.clinimag.2020.05.029.

    PMID: 32516693

This page is for informational purposes only and does not constitute medical advice. Your breast care team can tailor follow-up imaging and treatment to your pathology, procedure, and personal risk factors.